CoChat

Dynamic Expedition of Leading Mutations in SARS-CoV-2 Spike Glycoproteins

Open access
Hasan, Muhammad, He, Zhouyi, Jia, Mengqi, Leung, Alvin C. F., Natarajan, Kathiresan, Xu, Wentao, Yap, Shanqi, Zhou, Feng, Chen, Shihong, Su, Hailei, Zhu, Kaicheng, Su, Haibin · 2021 · Computational and Structural Biotechnology Journal

Preprint — published as 10.1016/j.csbj.2024.05.037 · Paper page

The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.

Abstract

Throughout the coronavirus disease 2019 (COVID-19) pandemic, the continuous genomic evolution of its etiological agent, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has generated many new variants with enhanced transmissibility and immune escape capabilities. Being an essential mediator of infections and a key target of antibodies, mutations of its spike glycoprotein play a vital role in modulating its evolutionary trajectory. Here, we present a time-resolved statistical method, Dynamic Expedition of Leading Mutations (deLemus), to analyze the evolutionary dynamics of the SARS-CoV-2 spike. Together with analysis of its single amino acid polymorphism (SAP), we propose the use of L -index in quantifying the mutation strength of each amino acid site, such that the evolutionary mutation pattern of the spike glycoprotein can be unravelled.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2021.12.29.474427

Cites

92 of 92 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Confirmed leading mutation sites (red spheres) in different domains of the SARS-CoV-2 spike glycoprotein. (a) A SARS-CoV-2 spike glycoprotein monomer (generated by AlphaFold2, Colab version, using the reference sequence EPI_ISL_402124) encompassing the four major functional domains: NTD, RBD, CTDs (CTD1&2), and S2. (b) Mutation sites outlined in the NTD (green), most of which are clustered in the outer regions. (c) Mutation sites outlined in the RBD (yellow), nearly all the captured mutations are located in the receptor-binding motif. (d) Mutation sites outlined in the CTDs (pink). (e) Mutation sites outlined in S2 (cyan).
Fig. 1 Confirmed leading mutation sites (red spheres) in different domains of the SARS-CoV-2 spike glycoprotein. (a) A SARS-CoV-2 spike glycoprotein monomer (generated by AlphaFold2, Colab version, using the reference sequence EPI_ISL_402124) encompassing the four major functional domains: NTD, RBD, CTDs (CTD1&2), and S2. (b) Mutation sites outlined in the NTD (green), most of which are clustered in the outer regions. (c) Mutation sites outlined in the RBD (yellow), nearly all the captured mutations are located in the receptor-binding motif. (d) Mutation sites outlined in the CTDs (pink). (e) Mutation sites outlined in S2 (cyan).CC BY-NC-ND · PubMed Central
Fig. 2 Evolutionary trajectory of the N-terminal domain (NTD). The x-axis denotes mutable sites within the domain. The y-axis represents time in months, spanning from January 2020 to December 2021. The Variants of Concern (VOCs) are represented by the following colors: red (α, B.1.1.7), light blue (β, B.1.351), purple (γ, P.1), green (δ, B.1.617.2), and blue (o, BA.1, BA.2). The Variants of Interest (VOIs) are depicted in pink: ϵ (B.1.427, B.1.429), ι (B.1.526), η (B.1.525), κ (B.1.617.1), λ (C.37), and μ (B.1.621). Reported mutations from VOCs and VOIs are depicted in gray. The orange circles represent the mutation outlined by the L-index. The vertical dashed lines indicate the confirmed mutations identified by the L-index within the reported VOCs/VOIs. Each circle is labeled with a letter representing the corresponding mutated amino acid, such as Δ (Deletion), A (Alanine), C (Cysteine), D (Aspartic Acid), etc. Unmarked circles correspond to the same amino acids as the labeled circles below.
Fig. 2 Evolutionary trajectory of the N-terminal domain (NTD). The x-axis denotes mutable sites within the domain. The y-axis represents time in months, spanning from January 2020 to December 2021. The Variants of Concern (VOCs) are represented by the following colors: red (α, B.1.1.7), light blue (β, B.1.351), purple (γ, P.1), green (δ, B.1.617.2), and blue (o, BA.1, BA.2). The Variants of Interest (VOIs) are depicted in pink: ϵ (B.1.427, B.1.429), ι (B.1.526), η (B.1.525), κ (B.1.617.1), λ (C.37), and μ (B.1.621). Reported mutations from VOCs and VOIs are depicted in gray. The orange circles represent the mutation outlined by the L-index. The vertical dashed lines indicate the confirmed mutations identified by the L-index within the reported VOCs/VOIs. Each circle is labeled with a letter representing the corresponding mutated amino acid, such as Δ (Deletion), A (Alanine), C (Cysteine), D (Aspartic Acid), etc. Unmarked circles correspond to the same amino acids as the labeled circles below.CC BY-NC-ND · PubMed Central
Fig. 3 Evolutionary trajectory of the receptor-binding domain (RBD). The annotations, labels, and color schemes in this figure are identical to those employed in Fig. 2.
Fig. 3 Evolutionary trajectory of the receptor-binding domain (RBD). The annotations, labels, and color schemes in this figure are identical to those employed in Fig. 2.CC BY-NC-ND · PubMed Central
Fig. 4 Data analysis on deep mutational scanning from published work [70]. (a) 3D structure illustration of leading mutations outlined in RBD (red). (b) RBD-ACE2 binding affinity distribution with different reference virus variants. (c) Escape score of leading mutation sites.
Fig. 4 Data analysis on deep mutational scanning from published work [70]. (a) 3D structure illustration of leading mutations outlined in RBD (red). (b) RBD-ACE2 binding affinity distribution with different reference virus variants. (c) Escape score of leading mutation sites.CC BY-NC-ND · PubMed Central
Fig. 5 Evolutionary trajectory of the C-terminal domains (CTD1 and CTD2). The annotations, labels, and color schemes in this figure are identical to those employed in Fig. 2.
Fig. 5 Evolutionary trajectory of the C-terminal domains (CTD1 and CTD2). The annotations, labels, and color schemes in this figure are identical to those employed in Fig. 2.CC BY-NC-ND · PubMed Central
Fig. 6 Evolutionary trajectory of the S2 subunit. The annotations, labels, and color schemes in this figure are identical to those employed in Fig. 2.
Fig. 6 Evolutionary trajectory of the S2 subunit. The annotations, labels, and color schemes in this figure are identical to those employed in Fig. 2.CC BY-NC-ND · PubMed Central
Fig. 7 Evolutionary trajectory of the BA.2.86 and JN.1. The annotations, labels, and color schemes in this figure are identical to those employed in Fig. 2.
Fig. 7 Evolutionary trajectory of the BA.2.86 and JN.1. The annotations, labels, and color schemes in this figure are identical to those employed in Fig. 2.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 8

  1. 2017, GISAID: Global initiative on sharing all influenza data – from vision to reality, Eurosurveillance, 22, 30494
  2. Golub, G. H. & Van Loan, C. F. Matrix Computations 4th ed., 780 (The Johns Hopkins University Press, Maryland, 2013).
  3. 2021, Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains, mBio, 12, e01590
  4. 2022, Conserved Pattern and Potential Role of Recurrent Deletions in SARS-CoV-2 Evolution, Microbiol. Spectr, 10, e02191
  5. 10.1016/S0140-6736(21)02758-6/ATTACHMENT/FB9D1AF8-6927-48BD-B7B7-A5055C3743D5/MMC1.PDF · doi:10.1016/s0140-6736(21)02758-6/attachment/fb9d1af8-6927-48bd-b7b7-a5055c3743d5/mmc1.pdf
  6. 2021, A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants, mBio, 12, e02473
  7. Gobeil, S. M.-C. , Janowska, K. , McDowell, S. , et al. D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction. Cell Rep. 34 (2021). · DOI · Paper page
  8. 2018, Complexities of Viral Mutation Rates, J. Virol, 92, e01031

Metadata

Authors
Hasan, M., He, Z., Jia, M., Leung, A. C. F., Natarajan, K., Xu, W., Yap, S., Zhou, F., Chen, S., Su, H., Zhu, K., & Su, H.
Affiliations
  • Hong Kong University of Science and Technology (HK)
  • Rajiv Gandhi Centre for Biotechnology (IN)
Corresponding author
  • Su, Hailei
  • Zhu, Kaicheng
  • Su, Haibin
Venue
Computational and Structural Biotechnology Journal
Publisher
openRxiv
Published
2021-12-29
Volume
23
Pages
2407-2417
ISSN
2001-0370 (ISSN-L)
OpenAlex
W4398765285
Cited by
3
References
92
Citations by year
2026: 2 · 2025: 1
FWCI
1.04
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Computational and Structural Biotechnology Journal (publishedVersion, cc-by-nc-nd)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Rare & Special e-Zone (The Hong Kong University of Science and Technology) (submittedVersion)
Funders
Hong Kong University of Science and Technology (R9418)
Topics
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
Keywords
SARS-CoV-2, spike protein, viral evolution, L-index, viral variants

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.